Healthcare, Pharma & Life Sciences

Viatris Named to Forbes World's Best Employers List for Sixth Year

Image
Viatris Named to Forbes World's Best Employers List for Sixth Year

Pittsburgh – September 29, 2026 -- Viatris Inc. (Nasdaq: VTRS) has been named to Forbes' World's Best Employers list for the sixth consecutive year, based on an independent survey of more than 300,000 employees across over 50 countries.

Forbes and Statista ranked 900 companies using employee trust and workplace culture data

The 2026 ranking, compiled by Forbes and Statista, drew on respondents who rated their willingness to recommend their employer on a 1-to-10 scale. Participants evaluated current and former employers across multiple workplace factors and could also weigh in on other companies within their country and industry.

Viatris cites the recognition as validation of its global workforce strategy

Lara Ramsburg, Chief People and Corporate Affairs Officer at Viatris, said the sixth straight placement reflects the contributions of colleagues worldwide who help the company support patients while fostering a collaborative culture.

Maryland Stem Cell Fund Awards $4.8M as Demand Outpaces Capital

Image
Maryland Stem Cell Fund Awards $4.8M as Demand Outpaces Capital

Columbia, Md. – September 29, 2026 -- The Maryland Stem Cell Research Commission has awarded more than $4.8 million through the Maryland Stem Cell Research Fund (MSCRF) in the first funding cycle of fiscal year 2027, backing 15 investigators across the state's regenerative medicine sector.

Applications for MSCRF funding continue to exceed available resources

Requested funding significantly outstripped the capital available for this cycle, according to the Commission, reflecting both the depth of Maryland's research base and a rising number of technologies advancing past early discovery into validation, clinical development and manufacturing—stages that require substantially more capital.

Solis Mammography Enters South Carolina Via HCA Trident JV

Image
Solis Mammography Enters South Carolina Via HCA Trident JV

Charleston, SC – – September 29, 2026 -- Solis Mammography has formed a joint venture with HCA Healthcare Trident Hospital, marking the company's first entry into South Carolina and its 26th major market nationwide.

Trident Hospital's breast imaging unit rebrands under the Solis name

The partnership converts Trident Hospital's existing breast imaging services into Solis Mammography, a department of HCA Healthcare Trident Hospital, located at 9313 Medical Plaza Dr., Suite 201, Charleston. The companies plan to expand the model into additional HCA Healthcare facilities across the greater Charleston area.

eMed, Female Quotient Partner to Close $1 Trillion Women's Health Gap

Miami – September 29, 2026 -- eMed, a digital healthcare company, and The Female Quotient, a global media and experiences firm reaching over 8 million leaders across 30 industries, have announced a strategic partnership targeting a $1 trillion annual opportunity in the global economy by 2040 tied to closing the women's health gap.

Partnership launches at New York summit on October 14

The collaboration will officially debut at the FQ Health Summit in New York City, where executives will discuss innovation to address disparities in women's healthcare access. Chloe Ferro and Olivia Ferro, founders of sheMed, will join the discussion to share perspectives on personalized care.

PBS Biotech Embeds Rockwell Automation Tech in Cell Therapy Bioreactor

Image
PBS Biotech Embeds Rockwell Automation Tech in Cell Therapy Bioreactor

Milwaukee – September 29, 2026 -- PBS Biotech has embedded Rockwell Automation technology into its MiniPRO multi-parallel bioreactor platform, a system with up to 24 independently controlled bioreactors designed to speed cell therapy process development and reduce risk during scale-up to commercial manufacturing.

Platform integrates FactoryTalk software with PlantPAx distributed control

The MiniPRO uses Rockwell's FactoryTalk software and Process Library to deliver real-time process control within an automation environment that can integrate directly into a larger PlantPAx distributed control system used to run an entire cell-therapy facility. Rockwell Automation, headquartered in Milwaukee and employing roughly 26,000 people across more than 100 countries as of fiscal year 2025, positions the collaboration as a way to standardize automation across development and GMP manufacturing stages.

Thyme Companies Names Flatiron Health Ex-CEO Starrett to Lead New Ventures

Image
Thyme Companies Names Flatiron Health Ex-CEO Starrett to Lead New Ventures

Nashville, Tenn. – – September 29, 2026 -- Thyme Companies has appointed Carolyn Starrett as executive vice president of new ventures, tasking her with identifying and scaling new businesses beyond its existing Thyme Care platform. Starrett reports directly to Executive Chairman Robin Shah, marking her second collaboration with him after their tenure together at Flatiron Health.

Starrett brings a decade of oncology data leadership from Flatiron Health

Starrett joined Flatiron Health in 2016 alongside Thyme's founders and served as its Chief Executive Officer from 2021 to 2025. Under her leadership, Flatiron's real-world evidence platform expanded from roughly 400,000 to more than 5.5 million patient records. Its OncoEMR platform grew to serve more than 4,500 oncology providers nationwide, while the company extended research operations into the United Kingdom, Germany and Japan.

Jack & Jill Foundation Marks 20 Years of Oncologist-Prescribed Family Trips

Atlanta – September 29, 2026 -- The Jack & Jill Late Stage Cancer Foundation (JAJF) has completed 20 years of funding fully-paid family trips for parents with terminal cancer diagnoses, a model now formally prescribed by oncologists across the United States as part of patient treatment protocols.

Foundation traces origin to a 2006 family diagnosis

Jon Albert founded JAJF in 2006 after his wife, Jill, was diagnosed with Stage IV metastatic breast cancer. Jill died two weeks after the foundation's launch, but the organization she inspired has since delivered what it calls WOW! Experiences to thousands of children and parents nationwide.

BioFuture 2026 Gathers 100+ Speakers to Tackle Biopharma AI, Funding, Policy

New York City – – September 29, 2026 -- Demy-Colton has released the agenda for BioFuture 2026, a two-day conference set for October 27–28 at Cure, 345 Park Avenue South, drawing more than 100 speakers and over 50 presenting companies from biopharma, investment, technology and policy sectors.

Conference agenda spans AI, oncology, biotech financing and global drug development

Speakers include representatives from Johnson & Johnson, Regeneron Pharmaceuticals, Schrödinger, Piper Sandler and Mizuho Securities. Sponsors backing the event include Regeneron Pharmaceuticals, Russo Partners, WuXi AppTec, Blue Matter, Cure, Evotec, Ipsen, Thermo Fisher Scientific, Big4Bio, HMA Consulting, Withum and Hogan Lovells Cadwalader.

Truven Launches AI Tool Cutting Data Feasibility Checks to Minutes

Image
Truven Launches AI Tool Cutting Data Feasibility Checks to Minutes

Ann Arbor – September 29, 2026 -- Truven has launched MarketScan Snapshot, an AI-powered search capability that compresses what the company says can be days or weeks of cohort feasibility research into a process taking minutes.

Snapshot lets researchers query 300 million cumulative patient lives in plain language

The tool allows users to run patient-count requests against MarketScan Research Databases using everyday language, eliminating the need to specify medical codes or possess programming skills. MarketScan's underlying dataset includes more than 300 million cumulative lives, 95 million active lives, 99% claims completeness, and data access dating back to 1995 across commercial, Medicare and Medicaid populations.

Survey: 79% of Cardiac Patients Want Home-Based Rehab, But Coverage Is Key

Campbell, Calif. – September 29, 2026 -- Vivalink, a digital healthcare solutions provider, published survey data showing 79% of more than 150 U.S. adults with cardiac conditions would participate in a home-based cardiac rehabilitation program if recommended by a provider.

Patients favor hybrid or home-based rehab over clinic visits

When given a choice, 68% of respondents said they would prefer a primarily home-based or hybrid rehabilitation approach over traditional in-clinic programs.

Insurance coverage ranks as the top barrier to participation

Fifty-eight percent of respondents ranked insurance coverage as their top consideration for participating in home-based care. Sixty percent said they would not pay out of pocket for such a program, while 87% said confirmed insurance coverage would increase their likelihood of participating.